Enoxaparin sodium injection

  • Favorite
Baiyu Pharmaceutical Co., Ltd.

Business Type:Manufacturer

Country/Region:China

Ddu Verified

HOT Rank

6/10

Product Information

  • Indication:1. Prevention of venous thromboembolic diseases (prevention of intravenous thrombosis), especially for thrombosis associated with orthopedic or general surgery. 2. Treatment of deep venous thrombosis
  • Specification:0.6ml:6000AxaIU
  • Dosage Form:Injection
  • Active Ingredients:Enoxaparin Sodium
  • Route of Administration:Intravenous Drip
  • Shelf Life:2 years
  • Storage:Sealed
  • Package:10 ampoules/box, 100 boxes/carton (Can be customized)
  • Place of Origin:China
  • Qualification:FDA

Description

The only product in China that bioequivalence is completely consistent with the original drug. Also, it has been manufactured and marketed in China for some years.

Active ingredient: Enoxaparin Sodium

Description: A colorless to pale yellow clear liquid.

Dosage form: liquid injection

Strength: 0.6ml: 6000AxaIU

Packaging size: 10 ampoules/box, 100 boxes/carton (Can be customized)

Indications:

1. Prevention of venous thromboembolic diseases (prevention of intravenous thrombosis), especially for thrombosis associated with orthopedic or general surgery.

2. Treatment of deep venous thrombosis with or without pulmonary embolism. Clinical symptoms are not serious and does not include pulmonary embolism requiring surgery or thrombolytic therapy.

3. Treatment for pulmonary embolism.

4. Treatment of unstable angina and non-Q-wave myocardial infarction when combined with aspirin.

5. Prevention of thrombogenesis in hemodialysis extracorporeal circulation.


You Might Also Like
Change a group
Inquiry Cart(0)